285 related articles for article (PubMed ID: 29187213)
1. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component.
Liu X; Si W; Liu X; He L; Ren J; Yang Z; Yang J; Li W; Liu S; Pei F; Yang X; Sun L
Mol Cancer; 2017 Nov; 16(1):175. PubMed ID: 29187213
[TBL] [Abstract][Full Text] [Related]
2. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
3. JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation.
Wang F; He L; Huangyang P; Liang J; Si W; Yan R; Han X; Liu S; Gui B; Li W; Miao D; Jing C; Liu Z; Pei F; Sun L; Shang Y
PLoS Biol; 2014 Mar; 12(3):e1001819. PubMed ID: 24667498
[TBL] [Abstract][Full Text] [Related]
4. JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner.
Yi J; Shen HF; Qiu JS; Huang MF; Zhang WJ; Ding JC; Zhu XY; Zhou Y; Fu XD; Liu W
Nucleic Acids Res; 2017 Apr; 45(6):3503-3518. PubMed ID: 27899633
[TBL] [Abstract][Full Text] [Related]
5. JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4.
Wan J; Liu H; Yang L; Ma L; Liu J; Ming L
Int J Cancer; 2019 May; 144(10):2489-2500. PubMed ID: 30125344
[TBL] [Abstract][Full Text] [Related]
6. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
Lee YF; Miller LD; Chan XB; Black MA; Pang B; Ong CW; Salto-Tellez M; Liu ET; Desai KV
Breast Cancer Res; 2012 May; 14(3):R85. PubMed ID: 22621393
[TBL] [Abstract][Full Text] [Related]
7. P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma.
Ong CC; Jubb AM; Jakubiak D; Zhou W; Rudolph J; Haverty PM; Kowanetz M; Yan Y; Tremayne J; Lisle R; Harris AL; Friedman LS; Belvin M; Middleton MR; Blackwood EM; Koeppen H; Hoeflich KP
J Natl Cancer Inst; 2013 May; 105(9):606-7. PubMed ID: 23535073
[TBL] [Abstract][Full Text] [Related]
8. H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis.
Park WY; Hong BJ; Lee J; Choi C; Kim MY
Cancer Res; 2016 Jan; 76(1):161-70. PubMed ID: 26729791
[TBL] [Abstract][Full Text] [Related]
9. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of JMJD6 expression reduces the proliferation, migration and invasion of neuroglioma stem cells.
Zhou DX; Zhou D; Zhan SQ; Wang P; Qin K; Gan W; Lin XF
Neoplasma; 2017; 64(5):700-708. PubMed ID: 28592121
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of PAK1 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer Cells Through the ERK Pathway.
Wang S; Wang SY; Du F; Han Q; Wang EH; Luo EJ; Liu Y
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):602-610. PubMed ID: 31394555
[TBL] [Abstract][Full Text] [Related]
12. KRas-ERK signalling promotes the onset and maintenance of uveal melanoma through regulating JMJD6-mediated H2A.X phosphorylation at tyrosine 39.
Li Y; Yu P; Zou Y; Cai W; Sun W; Han N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4257-4265. PubMed ID: 31736361
[TBL] [Abstract][Full Text] [Related]
13. Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production.
Palmer KR; Tong S; Tuohey L; Cannon P; Ye L; Hannan NJ; Brownfoot FC; Illanes SE; Kaitu'u-Lino TJ
Biol Reprod; 2016 Mar; 94(3):59. PubMed ID: 26819475
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of sFlt-1 splicing by U2AF65 and JMJD6 in placental-derived and endothelial cells.
Eddy AC; Chapman H; Brown DT; George EM
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32039444
[TBL] [Abstract][Full Text] [Related]
15. Role of JMJD6 in Breast Tumourigenesis.
Poulard C; Rambaud J; Lavergne E; Jacquemetton J; Renoir JM; Trédan O; Chabaud S; Treilleux I; Corbo L; Le Romancer M
PLoS One; 2015; 10(5):e0126181. PubMed ID: 25951181
[TBL] [Abstract][Full Text] [Related]
16. High expression of JMJD6 predicts unfavorable survival in lung adenocarcinoma.
Zhang J; Ni SS; Zhao WL; Dong XC; Wang JL
Tumour Biol; 2013 Aug; 34(4):2397-401. PubMed ID: 23595221
[TBL] [Abstract][Full Text] [Related]
17. Signaling events mediated by α3β1 integrin are essential for mammary tumorigenesis.
Cagnet S; Faraldo MM; Kreft M; Sonnenberg A; Raymond K; Glukhova MA
Oncogene; 2014 Aug; 33(34):4286-95. PubMed ID: 24077284
[TBL] [Abstract][Full Text] [Related]
18. Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.
Yang H; Liu Z; Yuan C; Zhao Y; Wang L; Hu J; Xie D; Wang L; Chen D
Int J Clin Exp Pathol; 2015; 8(9):11092-9. PubMed ID: 26617828
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation.
Li R; Zhang L; Jia L; Duan Y; Li Y; Bao L; Sha N
PLoS One; 2014; 9(6):e100893. PubMed ID: 24967732
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of RBP2-H1 variant of JARID1B in melanoma.
Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
BMC Cancer; 2017 Dec; 17(1):854. PubMed ID: 29246117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
